Bloodstream infection by multidrug-resistant Streptococcus oralis in a leukemic patient with febrile neutropenia after hematopoietic stem cell transplantation.
Adult
Anti-Bacterial Agents
/ therapeutic use
Bacteremia
/ diagnosis
Drug Resistance, Multiple, Bacterial
Febrile Neutropenia
/ complications
Female
Hematopoietic Stem Cell Transplantation
/ adverse effects
Humans
Leukemia
/ therapy
Microbial Sensitivity Tests
Streptococcal Infections
/ diagnosis
Streptococcus oralis
/ drug effects
Treatment Outcome
Streptococcus oralis
bloodstream infection
febrile neutropenia
multidrug resistance
teicoplanin
Journal
Transplant infectious disease : an official journal of the Transplantation Society
ISSN: 1399-3062
Titre abrégé: Transpl Infect Dis
Pays: Denmark
ID NLM: 100883688
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
07
09
2019
revised:
19
12
2019
accepted:
05
01
2020
pubmed:
17
1
2020
medline:
21
11
2020
entrez:
17
1
2020
Statut:
ppublish
Résumé
We reported the case of a patient with leukemia who developed febrile neutropenia after hematopoietic stem cell transplantation. Blood culture results revealed the presence of Streptococcus oralis, while antimicrobial susceptibility testing showed the resistance to penicillin and cephem. Furthermore, isolates were not susceptible to either meropenem or daptomycin but not to vancomycin. S oralis is known to belong to Streptococcus mitis group and be a causative agent of bacteremia in the neutropenic patients, but multidrug resistance of S oralis is rare. Our findings suggest that we might pay attention to the emergence of the microorganisms acquiring multidrug resistance in neutropenic patients.
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13246Informations de copyright
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Cattaneo C, Casari S, Bracchi F, et al. Recent increase in enterococci, viridans streptococci, Pseudomonas spp. and multiresistant strains among haematological patients, with a negative impact on outcome. Results of a 3-year surveillance study at a single institution. Scand J Infect Dis. 2010;42:324-332.
Marron A, Carratalà J, González-Barca E, Fernández-Sevilla A, Alcaide F, Gudiol F. Serious complications of bacteremia caused by viridans streptococci in neutropenic patients with cancer. Clin Infect Dis. 2000;31:1126-1130.
Facklam R. What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev. 2002;15:613-630.
Doyuk E, Ormerod OJ, Bowler ICJW. Native valve endocarditis due to Streptococcus vestibularis and Streptococcus oralis. J Infect. 2002;45:39-41.
Shelburne SA III, Lasky RE, Sahasrabhojane P, Tarrand JT, Rolston KVI. Development and validation of a clinical model to predict the presence of β-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients. Clin Infect Dis. 2014;59:223-230.
Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89:2079-2088.
Institute CaLS. Clinical and Laboratory Standards Institute. In: Institute CaLS, ed. Performance standards for antimicrobial susceptibility testing, Document M100-S27. Wayne, PA: CLSI; 2018:118-120.
Jensen A, Scholz CF, Kilian M. Re-evaluation of the taxonomy of the mitis group of the genus Streptococcus based on whole genome phylogenetic analyses, and proposed reclassification of Streptococcus dentisani as Streptococcus oralis subsp. dentisani comb. nov., Streptococcus tigurinus as Streptococcus oralis subsp. tigurinus comb. nov., and Streptococcus oligofermentans as a later synonym of Streptococcus cristatus. Int J Syst Evol Microbiol. 2016;66:4803-4820.
Nakano S, Fujisawa T, Ito Y, et al. Penicillin-binding protein typing, antibiotic resistance gene identification, and molecular phylogenetic analysis of meropenem-resistant Streptococcus pneumoniae serotype 19A-CC3111 strains in Japan. Antimicrob Agents Chemother. 2019;63:e00711-19.
Tran TT, Mishra NN, Seepersaud R, et al. Mutations in cdsA and pgsA correlate with daptomycin resistance in Streptococcus mitis and S oralis. Antimicrob Agents Chemother. 2019;63:e01531-18.
Tunkel AR, Sepkowitz KA. Infections caused by viridans streptococci in patients with neutropenia. Clin Infect Dis. 2002;34:1524-1529.
Reilly AF, Lange BJ. Infections with viridans group streptococci in children with cancer. Pediatr Blood Cancer. 2007;49:774-780.
Gudiol C, Garcia-Vidal C, Arnan M, et al. Etiology, clinical features and outcomes of pre-engraftment and post-engraftment bloodstream infection in hematopoietic SCT recipients. Bone Marrow Transplant. 2014;49:824-830.
Shelburne SA, Pranoti S, Miguel S, et al. Streptococcus mitisstrains causing severe clinical disease in cancer patients. Emerg Infect Dis. 2014;20:762-771.
Teng LJ, Hsueh PR, Chen YC, Ho SW, Luh KT. Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis. J Antimicrob Chemother. 1998;41:621-627.
Kimura M, Araoka H, Yoshida A, et al. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital. BMC Infect Dis. 2016;16:372.
Razonable RR, Litzow MR, Khaliq Y, Piper KE, Rouse MS, Patel R. Bacteremia due to viridans group streptococci with diminished susceptibility to levofloxacin among neutropenic patients receiving levofloxacin prophylaxis. Clin Infect Dis. 2002;34:1469-1474.
Nielsen MJ, Claxton S, Pizer B, et al. Viridans group streptococcal infections in children after chemotherapy or stem cell transplantation: a 10-year review from a tertiary pediatric hospital. Medicine. 2016;95:e2952.
Matsui N, Ito M, Kuramae H, Inukai T, Sakai A, Okugawa M. Infective endocarditis caused by multidrug-resistant Streptococcus mitis in a combined immunocompromised patient: an autopsy case report. J Infect Chemother. 2013;19:321-325.
Mishra NN, Tran TT, Seepersaud R, et al. Perturbations of phosphatidate cytidylyltransferase (CdsA) mediate daptomycin resistance in Streptococcus mitis/oralis by a novel mechanism. Antimicrob Agents Chemother. 2017;61:e02435-16.